Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.3 billion.
Market Cap
1.14T
Revenue
110.3B
Profits
-40.98B
PE Ratio
n/a
Profit Margin
-37.15%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.02B | 1.07% | 155,727 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.40B | 0.36% | 60,000 | 14.92B |
| 3 | ARGX | argenx SE | 49.13B | -0.53% | 74,945 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.69B | 0.46% | 89,657 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 35.24B | -0.01% | 32,963 | 5.74B |
| 6 | RPRX | Royalty Pharma plc | 30.20B | 1.47% | 377,136 | 2.44B |
| 7 | RVMD | Revolution Medicines, Inc. | 30.07B | -0.74% | 268,569 | - |
| 8 | BNTX | BioNTech SE | 23.59B | 0.30% | 116,087 | 3.23B |
| 9 | INSM | Insmed Incorporated | 22.95B | 0.84% | 1,900,603 | 819.56M |
| 10 | MRNA | Moderna, Inc. | 21.46B | 11.41% | 3,662,828 | 2.23B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.35B | 0.57% | 657,968 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.63B | 0.51% | 101,239 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.00B | -3.99% | 2,310,865 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.11B | -0.65% | 119,679 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.21B | -0.22% | 94,440 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.55B | 1.81% | 811,836 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.15B | -0.42% | 719,110 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.71B | 1.13% | 131,930 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 11.97B | 3.03% | 384,207 | 2.38B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | -3.24% | 54,698 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.35B | 0.12% | 103,949 | 708.24M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | 0.04% | 191,715 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.43B | -4.46% | 616,032 | 622.01M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.04B | -1.03% | 197,767 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.56B | 3.42% | 478,049 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.34B | 0.67% | 52,036 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.81B | 0.67% | 76,477 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 8.46B | 4.62% | 70,534 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.01B | - | 2,138,144 | 140.98M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.69B | -0.41% | 183,750 | 1.40B |
| 31 | PCVX | Vaxcyte, Inc. | 7.62B | 2.51% | 217,021 | - |
| 32 | TECH | Bio-Techne Corporation | 7.51B | -5.77% | 685,845 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.03B | 0.93% | 40,691 | 51.48M |
| 34 | MIRM | Mirum Pharmaceuticals, Inc. | 6.56B | 4.50% | 824,787 | 569.61M |
| 35 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.56B | -0.58% | 115,899 | 217.17M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.42B | 1.19% | 123,445 | - |
| 37 | CELC | Celcuity Inc. | 6.35B | 0.52% | 82,372 | - |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 6.33B | -0.36% | 37,965 | 74.06M |
| 39 | TGTX | TG Therapeutics, Inc. | 6.26B | 2.61% | 419,027 | 700.35M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.25B | 2.21% | 75,527 | - |
| 41 | BLTE | Belite Bio, Inc | 6.18B | 0.63% | 3,541 | - |
| 42 | CGON | CG Oncology, Inc. | 6.16B | 1.19% | 77,375 | 5.07M |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.10% | 159,455 | 15.00M |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.11B | 14.31% | 1,101,150 | 827.11M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.97B | 0.34% | 125,997 | - |
| 46 | IMVT | Immunovant, Inc. | 5.75B | 3.78% | 79,911 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.60B | 1.10% | 81,752 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.52B | 0.65% | 106,123 | 769.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.47B | 1.05% | 142,118 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.37B | 1.68% | 468,621 | 1.03B |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | 0.01% | 556,767 | 1.11B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.17B | 2.31% | 239,950 | 4.10M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.72B | 1.05% | 38,391 | 1.34M |
| 54 | CAI | Caris Life Sciences, Inc. | 4.62B | -17.69% | 2,898,271 | 907.29M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.62B | 15.18% | 1,560,677 | 22.57M |
| 56 | MANE | Veradermics, Incorporated | 4.52B | 1.80% | 42,364 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.30B | 2.13% | 31,515 | 274.48M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.02B | -11.70% | 1,152,449 | 18.07M |
| 59 | TVTX | Travere Therapeutics, Inc. | 3.97B | 0.05% | 311,634 | 536.20M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.89B | 1.40% | 186,970 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.88B | 0.35% | 332,266 | 1.10B |
| 62 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.06% | 1,048,971 | 588.99M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.80B | -0.59% | 148,289 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.67B | -0.02% | 234,080 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.63B | 0.56% | 122,346 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.33B | -1.62% | 205,614 | 62.38M |
| 67 | ERAS | Erasca, Inc. | 3.23B | - | 640,584 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 3.18B | 0.99% | 194,099 | 164.01M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.16B | 1.12% | 220,906 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.13B | 0.28% | 178,451 | 236.00M |
| 71 | KLRA | Kailera Therapeutics, Inc. | 3.06B | 4.98% | 55,968 | - |
| 72 | ALMS | Alumis Inc. | 3.05B | 0.76% | 49,696 | 24.05M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.92B | 0.68% | 111,141 | - |
| 74 | NKTR | Nektar Therapeutics | 2.77B | -1.58% | 169,847 | 55.23M |
| 75 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -0.01% | 408,390 | 285.01M |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | -0.13% | 36,629 | 535.08M |
| 77 | GPCR | Structure Therapeutics Inc. | 2.73B | -1.79% | 181,737 | - |
| 78 | KOD | Kodiak Sciences Inc. | 2.64B | -2.70% | 111,033 | - |
| 79 | VERA | Vera Therapeutics, Inc. | 2.63B | 2.15% | 75,737 | - |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.60B | -0.42% | 110,611 | 865.00K |
| 81 | IRON | Disc Medicine, Inc. | 2.60B | 0.81% | 91,049 | - |
| 82 | IMNM | Immunome, Inc. | 2.57B | 2.12% | 82,578 | 6.94M |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | - | 170,274 | 670.00M |
| 84 | ARQT | Arcutis Biotherapeutics, Inc. | 2.56B | -0.77% | 401,254 | 415.62M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.56B | 4.32% | 125,737 | - |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.51B | 1.10% | 66,848 | 225.27M |
| 87 | DFTX | Definium Therapeutics, Inc. | 2.44B | -3.75% | 365,326 | - |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | 0.51% | 66,088 | - |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.40B | 0.24% | 263,449 | 10.68M |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.16B | 8.04% | 302,884 | - |
| 91 | ZLAB | Zai Lab Limited | 2.14B | -3.67% | 375,321 | 453.28M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.13B | 0.31% | 395,765 | 52.04M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.12B | -3.37% | 562,506 | 2.18B |
| 94 | NBTX | Nanobiotix S.A. | 2.05B | -1.46% | 8,586 | 38.27M |
| 95 | PHVS | Pharvaris N.V. | 2.02B | 4.08% | 54,659 | - |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.01B | -1.46% | 73,847 | 32.08M |
| 97 | AAPG | Ascentage Pharma Group International | 2.00B | -1.24% | 1,172 | 82.08M |
| 98 | TYRA | Tyra Biosciences, Inc. | 2.00B | 2.22% | 59,384 | - |
| 99 | ADMA | ADMA Biologics, Inc. | 2.00B | 1.42% | 2,126,634 | 509.86M |
| 100 | SION | Sionna Therapeutics, Inc. | 1.98B | 1.36% | 59,969 | - |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | 0.73% | 177,975 | 298.30M |
| 102 | NTLA | Intellia Therapeutics, Inc. | 1.98B | 3.21% | 888,213 | 67.67M |
| 103 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | 2.70% | 184,895 | 7.47M |
| 104 | ANAB | AnaptysBio, Inc. | 1.92B | -0.01% | 46,272 | 234.60M |
| 105 | OCS | Oculis Holding AG | 1.91B | 3.80% | 130,170 | 1.51M |
| 106 | RAPP | Rapport Therapeutics, Inc. | 1.91B | -0.08% | 52,818 | 20.00M |
| 107 | MESO | Mesoblast Limited | 1.90B | -1.69% | 24,154 | 65.38M |
| 108 | INBX | Inhibrx Biosciences, Inc. | 1.88B | 3.20% | 53,107 | 1.30M |
| 109 | MBX | MBX Biosciences, Inc. | 1.86B | 12.36% | 454,150 | - |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 1.44% | 82,577 | 217.17M |
| 111 | ZYME | Zymeworks Inc. | 1.84B | -6.11% | 187,903 | 81.26M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.84B | 6.00% | 45,819 | 31.89M |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.83B | 0.86% | 85,210 | 899.11M |
| 114 | ARDX | Ardelyx, Inc. | 1.77B | 2.44% | 596,133 | 427.68M |
| 115 | NVAX | Novavax, Inc. | 1.71B | 12.68% | 3,926,291 | 596.34M |
| 116 | VRDN | Viridian Therapeutics, Inc. | 1.71B | -2.47% | 720,692 | 70.92M |
| 117 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -1.22% | 3,075,062 | 66.41M |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.70B | -13.35% | 688,355 | 11.13M |
| 119 | NUVB | Nuvation Bio Inc. | 1.70B | 1.46% | 419,168 | 143.05M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 0.92% | 82,643 | 71.78M |
| 121 | INVA | Innoviva, Inc. | 1.70B | 0.48% | 79,020 | 420.69M |
| 122 | GLUE | Monte Rosa Therapeutics, Inc. | 1.68B | 0.66% | 54,711 | 42.95M |
| 123 | VCEL | Vericel Corporation | 1.67B | -6.48% | 257,050 | 292.09M |
| 124 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 2.16% | 43,226 | - |
| 125 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 1.09% | 69,135 | 66.05M |
| 126 | IMCR | Immunocore Holdings plc | 1.53B | -1.40% | 25,638 | 412.81M |
| 127 | ABCL | AbCellera Biologics Inc. | 1.53B | 4.77% | 1,944,816 | 75.13M |
| 128 | QURE | uniQure N.V. | 1.53B | 0.21% | 461,348 | 18.09M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.52B | 1.73% | 258,943 | 65.50M |
| 130 | IMTX | Immatics N.V. | 1.51B | 1.26% | 52,640 | 56.67M |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.51B | -0.32% | 40,007 | - |
| 132 | DMRA | Damora Therapeutics, Inc. | 1.51B | 0.04% | 17,529 | - |
| 133 | PGEN | Precigen, Inc. | 1.48B | 0.48% | 276,332 | 9.68M |
| 134 | URGN | UroGen Pharma Ltd. | 1.47B | 13.69% | 663,940 | 140.49M |
| 135 | BHVN | Biohaven Ltd. | 1.47B | 0.21% | 108,236 | - |
| 136 | ATAI | AtaiBeckley Inc. | 1.47B | -0.25% | 470,491 | 4.09M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.43B | 1.51% | 49,971 | 2.50M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -2.25% | 2,812,744 | 285.61M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.43B | -3.21% | 212,657 | 2.71B |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.02% | 703,657 | 73.62M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.39B | - | 287,527 | 71.80M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 2.36% | 44,551 | - |
| 143 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | -0.43% | 62,555 | - |
| 144 | SVRA | Savara Inc. | 1.31B | - | 151,671 | - |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -1.46% | 17,724 | - |
| 146 | GHRS | GH Research PLC | 1.30B | -0.33% | 28,995 | - |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.29B | 5.55% | 165,225 | - |
| 148 | JBIO | Jade Biosciences, Inc. | 1.28B | 6.90% | 98,022 | - |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.24B | 0.17% | 52,205 | - |
| 150 | DBVT | DBV Technologies S.A. | 1.17B | -1.15% | 9,952 | 5.74M |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 1.30% | 31,100 | 10.00M |
| 152 | AVLN | Avalyn Pharma Inc. | 1.16B | 2.95% | 18,009 | - |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.15B | 13.07% | 3,654,264 | 204.73M |
| 154 | EYPT | EyePoint, Inc. | 1.13B | 0.75% | 85,380 | 7.61M |
| 155 | COAG | Hemab Therapeutics Holdings, Inc. | 1.13B | -1.05% | 37,649 | - |
| 156 | IVA | Inventiva S.A. | 1.10B | 0.56% | 23,142 | 7.94M |
| 157 | SEPN | Septerna, Inc. | 1.09B | 1.54% | 19,589 | 45.95M |
| 158 | MNKD | MannKind Corporation | 1.09B | -0.42% | 2,300,563 | 360.78M |
| 159 | OMER | Omeros Corporation | 1.05B | -0.82% | 127,412 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 1.05B | 0.37% | 24,855 | 6.50M |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 975.40M | 0.41% | 80,569 | 204.89M |
| 162 | SANA | Sana Biotechnology, Inc. | 974.02M | 0.29% | 236,280 | - |
| 163 | LBRX | LB Pharmaceuticals Inc | 941.28M | 2.64% | 11,504 | - |
| 164 | ANNX | Annexon, Inc. | 936.04M | 4.35% | 682,496 | - |
| 165 | GERN | Geron Corporation | 930.21M | -0.68% | 3,746,792 | 196.12M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 924.41M | 1.36% | 242,245 | - |
| 167 | XNCR | Xencor, Inc. | 922.32M | 1.06% | 52,031 | 97.36M |
| 168 | SLS | SELLAS Life Sciences Group, Inc. | 913.44M | 0.41% | 518,419 | - |
| 169 | MGTX | MeiraGTx Holdings plc | 907.99M | 1.34% | 47,830 | 81.39M |
| 170 | CGEM | Cullinan Therapeutics, Inc. | 903.95M | -0.07% | 118,527 | - |
| 171 | DSGN | Design Therapeutics, Inc. | 902.50M | 2.48% | 23,484 | - |
| 172 | VOR | Vor Biopharma Inc. | 902.19M | 3.54% | 141,488 | - |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 887.72M | -0.67% | 259,388 | 84.28M |
| 174 | EVMN | Evommune, Inc. | 886.77M | 9.42% | 96,385 | 10.00M |
| 175 | JANX | Janux Therapeutics, Inc. | 882.72M | -0.41% | 211,022 | 13.73M |
| 176 | DRUG | Bright Minds Biosciences Inc. | 867.50M | 0.21% | 24,052 | - |
| 177 | TBPH | Theravance Biopharma, Inc. | 863.39M | -1.53% | 40,962 | 109.78M |
| 178 | ABSI | Absci Corporation | 861.18M | -3.65% | 2,712,581 | 1.84M |
| 179 | PHAR | Pharming Group N.V. | 860.79M | 7.42% | 8,030 | 369.49M |
| 180 | ABUS | Arbutus Biopharma Corporation | 860.63M | 0.46% | 57,271 | 14.08M |
| 181 | CTMX | CytomX Therapeutics, Inc. | 859.89M | -1.25% | 1,319,070 | 76.20M |
| 182 | ANRO | Alto Neuroscience, Inc. | 853.18M | 1.12% | 20,859 | - |
| 183 | KURA | Kura Oncology, Inc. | 836.14M | 1.07% | 104,915 | 67.48M |
| 184 | SPTX | Seaport Therapeutics, Inc. | 830.95M | 1.10% | 32,596 | - |
| 185 | SGP | SpyGlass Pharma, Inc. | 827.98M | -2.44% | 12,881 | - |
| 186 | ALLO | Allogene Therapeutics, Inc. | 804.91M | 3.08% | 1,176,638 | 22.00K |
| 187 | RLMD | Relmada Therapeutics, Inc. | 776.17M | -0.40% | 62,096 | - |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 726.61M | 2.08% | 888,282 | 69.64M |
| 189 | GYRE | Gyre Therapeutics, Inc. | 711.94M | 3.82% | 6,434 | 117.05M |
| 190 | SLDB | Solid Biosciences Inc. | 706.61M | 1.56% | 66,864 | - |
| 191 | DRTS | Alpha Tau Medical Ltd. | 693.52M | 0.38% | 51,220 | - |
| 192 | TENX | Tenax Therapeutics, Inc. | 682.40M | -0.52% | 100,926 | - |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 679.23M | 4.45% | 649,774 | 122.29M |
| 194 | STRO | Sutro Biopharma, Inc. | 676.96M | 2.59% | 30,983 | 102.48M |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 674.58M | -0.62% | 157,409 | 8.37M |
| 196 | ARVN | Arvinas, Inc. | 651.76M | - | 86,413 | 262.60M |
| 197 | CABA | Cabaletta Bio, Inc. | 627.74M | -3.75% | 1,454,297 | - |
| 198 | CRMD | CorMedix Inc. | 625.07M | 0.63% | 225,977 | 311.71M |
| 199 | TRAX | First Tracks Biotherapeutics, Inc. | 623.57M | 0.70% | 59,829 | - |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 621.05M | -1.27% | 31,389 | - |
| 201 | FBRX | Forte Biosciences, Inc. | 619.05M | -3.36% | 15,238 | - |
| 202 | ALT | Altimmune, Inc. | 602.02M | 1.97% | 507,740 | 41.00K |
| 203 | CADL | Candel Therapeutics, Inc. | 599.16M | 5.01% | 600,231 | - |
| 204 | CBIO | Crescent Biopharma, Inc. | 597.79M | -0.06% | 18,765 | 11.88M |
| 205 | PRTA | Prothena Corporation plc | 595.93M | 5.23% | 225,452 | 57.94M |
| 206 | PRME | Prime Medicine, Inc. | 584.57M | 5.94% | 447,446 | 4.03M |
| 207 | AVTX | Avalo Therapeutics, Inc. | 577.03M | -5.55% | 206,789 | 59.00K |
| 208 | PROK | ProKidney Corp. | 567.69M | - | 158,766 | 893.00K |
| 209 | CLYM | Climb Bio, Inc. | 565.58M | -0.59% | 52,777 | - |
| 210 | AGMB | AgomAb Therapeutics NV | 558.96M | -0.61% | 6,731 | - |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 552.04M | -1.94% | 64,870 | - |
| 212 | CTNM | Contineum Therapeutics, Inc. | 551.45M | 0.96% | 6,164 | - |
| 213 | RGNX | REGENXBIO Inc. | 550.76M | 2.40% | 216,347 | 170.44M |
| 214 | VALN | Valneva SE | 546.89M | 0.63% | 2,323 | 205.07M |
| 215 | MDXG | MiMedx Group, Inc. | 545.14M | -0.81% | 200,608 | 389.42M |
| 216 | TECX | Tectonic Therapeutic, Inc. | 533.04M | 5.25% | 128,500 | - |
| 217 | ANL | Adlai Nortye Ltd. | 532.40M | -2.85% | 15,282 | 5.00M |
| 218 | AURA | Aura Biosciences, Inc. | 531.57M | 0.98% | 48,691 | - |
| 219 | IMMX | Immix Biopharma, Inc. | 521.11M | 3.04% | 141,888 | - |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.13M | -14.24% | 723,510 | 151.40M |
| 221 | PRLD | Prelude Therapeutics Incorporated | 511.81M | -1.17% | 50,296 | 12.14M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 504.19M | -2.87% | 112,501 | 88.24M |
| 223 | XOMA | XOMA Royalty Corporation | 496.41M | 0.90% | 21,067 | 52.15M |
| 224 | OCGN | Ocugen, Inc. | 492.54M | 1.04% | 2,215,711 | 4.47M |
| 225 | UPB | Upstream Bio, Inc. | 490.32M | 0.28% | 46,117 | 2.85M |
| 226 | RIGL | Rigel Pharmaceuticals, Inc. | 488.82M | 0.69% | 66,185 | 299.77M |
| 227 | STTK | Shattuck Labs, Inc. | 488.26M | 3.19% | 96,482 | 1.00M |
| 228 | EIKN | Eikon Therapeutics, Inc. | 488.06M | -1.69% | 38,090 | - |
| 229 | NGNE | Neurogene Inc. | 477.61M | -2.16% | 9,085 | 925.00K |
| 230 | ADCT | ADC Therapeutics SA | 474.42M | -0.53% | 218,543 | 79.18M |
| 231 | OVID | Ovid Therapeutics Inc. | 472.39M | - | 414,383 | 7.25M |
| 232 | LYEL | Lyell Immunopharma, Inc. | 472.02M | 0.85% | 7,341 | 31.00K |
| 233 | SGMT | Sagimet Biosciences Inc. | 467.46M | -0.92% | 243,666 | - |
| 234 | ASMB | Assembly Biosciences, Inc. | 464.38M | -5.53% | 33,955 | 72.30M |
| 235 | FULC | Fulcrum Therapeutics, Inc. | 463.77M | 1.16% | 90,316 | 80.00M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 462.22M | -2.48% | 11,321 | - |
| 237 | VSTM | Verastem, Inc. | 443.61M | -10.78% | 1,740,392 | 49.59M |
| 238 | ENTA | Enanta Pharmaceuticals, Inc. | 442.84M | 1.13% | 29,204 | 66.98M |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 439.75M | -0.81% | 17,468 | - |
| 240 | LXEO | Lexeo Therapeutics, Inc. | 438.22M | 1.63% | 124,577 | - |
| 241 | AUTL | Autolus Therapeutics plc | 433.81M | 1.24% | 197,750 | 75.39M |
| 242 | ZURA | Zura Bio Limited | 429.81M | -0.22% | 61,429 | - |
| 243 | MNPR | Monopar Therapeutics Inc. | 429.10M | 2.71% | 32,328 | - |
| 244 | LRMR | Larimar Therapeutics, Inc. | 426.96M | 2.75% | 535,477 | - |
| 245 | PRTC | PureTech Health plc | 424.14M | 1.24% | 18,012 | 4.66M |
| 246 | IVVD | Invivyd, Inc. | 421.38M | 4.20% | 441,408 | 53.43M |
| 247 | IPSC | Century Therapeutics, Inc. | 414.81M | -0.43% | 44,856 | 109.16M |
| 248 | BNTC | Benitec Biopharma Inc. | 411.40M | -1.07% | 7,095 | - |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 405.04M | 1.09% | 532,816 | - |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 397.32M | 1.86% | 63,289 | 9.01M |
| 251 | PBYI | Puma Biotechnology, Inc. | 394.41M | 6.75% | 271,236 | 227.17M |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 387.87M | 0.94% | 208,411 | 217.78M |
| 253 | VTVT | vTv Therapeutics Inc. | 384.70M | -0.13% | 1,317 | 17.00K |
| 254 | YDES | YD Bio Limited | 372.10M | -1.54% | 53 | 510.36K |
| 255 | IRD | Opus Genetics, Inc. | 365.58M | -4.48% | 208,870 | 14.20M |
| 256 | NAUT | Nautilus Biotechnology, Inc. | 356.46M | -2.60% | 51,160 | - |
| 257 | DMAC | DiaMedica Therapeutics Inc. | 351.31M | -0.15% | 15,059 | - |
| 258 | IKT | Inhibikase Therapeutics, Inc. | 347.72M | 2.51% | 83,640 | 1.00 |
| 259 | BCYC | Bicycle Therapeutics plc | 341.56M | 0.20% | 28,398 | 63.50M |
| 260 | NMRA | Neumora Therapeutics, Inc. | 339.80M | -4.12% | 384,684 | - |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 339.26M | -0.58% | 278,308 | 14.56M |
| 262 | CCCC | C4 Therapeutics, Inc. | 338.26M | 3.02% | 397,147 | 35.95M |
| 263 | NAGE | Niagen Bioscience, Inc. | 337.84M | 0.48% | 451,102 | 130.42M |
| 264 | ABEO | Abeona Therapeutics Inc. | 337.31M | 2.77% | 212,929 | 5.82M |
| 265 | SRZN | Surrozen, Inc. | 337.02M | -4.59% | 27,319 | 7.49M |
| 266 | IMRX | Immuneering Corporation | 334.81M | -0.86% | 112,511 | - |
| 267 | RZLT | Rezolute, Inc. | 332.39M | 3.56% | 99,829 | - |
| 268 | CMPX | Compass Therapeutics, Inc. | 331.36M | 1.66% | 1,435,833 | 850.00K |
| 269 | ARMP | Armata Pharmaceuticals, Inc. | 330.07M | -1.69% | 6,489 | 4.90M |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 323.71M | -1.08% | 29,144 | - |
| 271 | SLN | Silence Therapeutics plc | 317.41M | -3.31% | 3,413 | 559.00K |
| 272 | PALI | Palisade Bio, Inc. | 316.43M | -5.03% | 375,360 | - |
| 273 | LENZ | LENZ Therapeutics, Inc. | 309.78M | 1.65% | 98,599 | 19.09M |
| 274 | NGEN | NervGen Pharma Corp. | 308.35M | -1.04% | 11,917 | - |
| 275 | EDIT | Editas Medicine, Inc. | 306.45M | 3.30% | 236,399 | 38.69M |
| 276 | ZNTL | Zentalis Pharmaceuticals, Inc. | 302.88M | 0.95% | 138,423 | 26.87M |
| 277 | ELDN | Eledon Pharmaceuticals, Inc. | 300.07M | 2.33% | 331,912 | - |
| 278 | ARTV | Artiva Biotherapeutics, Inc. | 298.33M | -3.59% | 3,202,718 | 251.00K |
| 279 | AVXL | Anavex Life Sciences Corp. | 297.94M | 3.04% | 198,415 | - |
| 280 | TARA | Protara Therapeutics, Inc. | 291.27M | -1.49% | 135,993 | - |
| 281 | ACIU | AC Immune SA | 285.20M | -1.54% | 80,428 | 4.62M |
| 282 | REPL | Replimune Group, Inc. | 281.99M | 2.25% | 510,736 | - |
| 283 | FATE | Fate Therapeutics, Inc. | 280.24M | -0.82% | 775,648 | 6.65M |
| 284 | CLLS | Cellectis S.A. | 278.03M | -0.08% | 162 | 79.59M |
| 285 | CGEN | Compugen Ltd. | 275.63M | 1.92% | 105,111 | 72.76M |
| 286 | CHRS | Coherus Oncology, Inc. | 274.51M | 1.14% | 163,018 | 42.17M |
| 287 | NVCT | Nuvectis Pharma, Inc. | 274.01M | 0.10% | 7,709 | - |
| 288 | SABS | SAB Biotherapeutics, Inc. | 271.97M | -5.38% | 490,683 | 114.70K |
| 289 | ACHV | Achieve Life Sciences, Inc. | 266.20M | 4.38% | 357,516 | - |
| 290 | NERV | Minerva Neurosciences, Inc. | 263.49M | -1.88% | 7,128 | - |
| 291 | HELP | Cybin Inc. | 263.19M | -1.50% | 162,809 | - |
| 292 | NBP | NovaBridge Biosciences | 254.43M | -0.90% | 136,463 | - |
| 293 | FHTX | Foghorn Therapeutics Inc. | 248.89M | 0.95% | 70,407 | 28.22M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 248.57M | 3.68% | 27,460 | 1.78M |
| 295 | VYGR | Voyager Therapeutics, Inc. | 247.11M | 3.28% | 145,098 | 36.49M |
| 296 | ALEC | Alector, Inc. | 245.92M | -9.22% | 200,159 | 21.05M |
| 297 | TRDA | Entrada Therapeutics, Inc. | 244.79M | -2.19% | 291,887 | 5.74M |
| 298 | CDXS | Codexis, Inc. | 243.60M | 3.88% | 316,360 | 78.09M |
| 299 | ALXO | ALX Oncology Holdings Inc. | 243.55M | -3.21% | 182,957 | - |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 242.99M | 1.45% | 8,836 | 44.64M |
| 301 | ADAG | Adagene Inc. | 239.84M | 1.40% | 35,495 | 7.67M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 239.61M | -5.28% | 214,168 | 54.71M |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 237.59M | 3.31% | 35,098 | 33.48M |
| 304 | OABI | OmniAb, Inc. | 237.44M | 11.56% | 928,312 | 28.94M |
| 305 | HRTX | Heron Therapeutics, Inc. | 234.86M | 0.40% | 261,501 | 154.90M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 233.03M | 0.53% | 154,631 | 1.55M |
| 307 | NKTX | Nkarta, Inc. | 230.98M | 2.86% | 164,078 | - |
| 308 | KROS | Keros Therapeutics, Inc. | 230.53M | 0.09% | 23,411 | 244.06M |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 228.83M | 0.66% | 4,322 | 19.39M |
| 310 | HUMA | Humacyte, Inc. | 227.57M | -5.09% | 1,605,831 | 2.04M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 221.72M | -1.61% | 1,492 | 3.50M |
| 312 | MDWD | MediWound Ltd. | 218.49M | -1.56% | 14,440 | 16.96M |
| 313 | CNTX | Context Therapeutics Inc. | 212.24M | -0.86% | 86,721 | - |
| 314 | RNA | Atrium Therapeutics, Inc. | 203.09M | 1.00% | 22,769 | 18.62M |
| 315 | UNCY | Unicycive Therapeutics, Inc. | 201.90M | 1.78% | 61,340 | - |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 201.31M | 0.90% | 14,565 | 146.07M |
| 317 | DTIL | Precision BioSciences, Inc. | 201.26M | 4.28% | 24,065 | 45.07M |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 199.02M | 2.86% | 42,316 | 13.11M |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 196.72M | 1.02% | 6,753 | 7.15M |
| 320 | TLSA | Tiziana Life Sciences Ltd | 195.26M | 1.32% | 16,807 | - |
| 321 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 194.04M | 0.64% | 13,784 | - |
| 322 | MGNX | MacroGenics, Inc. | 193.54M | 3.57% | 145,272 | 149.50M |
| 323 | IFRX | InflaRx N.V. | 192.30M | 0.38% | 1,518,520 | 33.82K |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 191.26M | 3.89% | 2,392,279 | 225.00K |
| 325 | ENLV | Enlivex Ltd. | 190.43M | -1.63% | 69,130 | - |
| 326 | CRBU | Caribou Biosciences, Inc. | 189.64M | 2.66% | 266,507 | 11.16M |
| 327 | ELTX | Elicio Therapeutics, Inc. | 189.48M | 2.90% | 29,605 | - |
| 328 | PLYX | Polaryx Therapeutics, Inc. | 189.37M | 4.71% | 20,547 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 181.65M | 1.82% | 41,951 | - |
| 330 | KRRO | Korro Bio, Inc. | 177.97M | -4.27% | 70,855 | 3.84M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 171.87M | 10.29% | 432,172 | 70.00M |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 167.70M | -0.67% | 161,404 | - |
| 333 | PYXS | Pyxis Oncology, Inc. | 165.25M | 16.37% | 507,544 | 13.86M |
| 334 | ANTX | AN2 Therapeutics, Inc. | 163.42M | -1.30% | 21,589 | - |
| 335 | PRQR | ProQR Therapeutics N.V. | 163.31M | -1.90% | 141,366 | 19.19M |
| 336 | KZIA | Kazia Therapeutics Limited | 161.69M | 5.52% | 68,367 | 1.27M |
| 337 | MENS | Jyong Biotech Ltd. | 159.95M | 1.46% | 12,565 | - |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 159.76M | 1.02% | 23,547 | 2.00M |
| 339 | IMUX | Immunic, Inc. | 159.12M | -0.43% | 35,839 | - |
| 340 | OKUR | OnKure Therapeutics, Inc. | 158.75M | -0.76% | 11,201 | - |
| 341 | PLX | Protalix BioTherapeutics, Inc. | 156.71M | -1.77% | 129,323 | 52.74M |
| 342 | MOLN | Molecular Partners AG | 155.82M | 3.66% | 73 | 856.30K |
| 343 | SPRB | Spruce Biosciences, Inc. | 154.08M | 0.80% | 1,346 | 697.00K |
| 344 | EDSA | Edesa Biotech, Inc. | 151.77M | -2.01% | 86,107 | - |
| 345 | NTHI | NeOnc Technologies Holdings, Inc. | 151.64M | -7.24% | 42,663 | 39.99K |
| 346 | SPRO | Spero Therapeutics, Inc. | 147.65M | 1.59% | 113,589 | 66.80M |
| 347 | HURA | TuHURA Biosciences, Inc. | 147.50M | -3.33% | 73,333 | - |
| 348 | AGEN | Agenus Inc. | 147.45M | 2.40% | 87,947 | 114.20M |
| 349 | EQ | Equillium, Inc. | 140.36M | 3.74% | 41,542 | 4.39M |
| 350 | IPHA | Innate Pharma S.A. | 138.93M | 2.92% | 1,233 | 10.57M |
| 351 | VRCA | Verrica Pharmaceuticals Inc. | 138.63M | -2.06% | 11,094 | 35.58M |
| 352 | ALPS | Alps Group Inc | 137.80M | -0.70% | 1,421 | 3.74M |
| 353 | GALT | Galectin Therapeutics Inc. | 137.58M | -0.95% | 38,398 | - |
| 354 | CNTB | Connect Biopharma Holdings Limited | 134.52M | 2.15% | 42,885 | 64.00K |
| 355 | ACOG | Alpha Cognition Inc. | 133.69M | 0.82% | 1,458 | 10.22M |
| 356 | GNLX | Genelux Corporation | 133.12M | 6.01% | 40,647 | 8.00K |
| 357 | PEPG | PepGen Inc. | 127.27M | 2.79% | 71,396 | - |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 120.48M | 1.75% | 7,657 | - |
| 359 | AARD | Aardvark Therapeutics, Inc. | 120.21M | -1.61% | 13,480 | - |
| 360 | INO | Inovio Pharmaceuticals, Inc. | 117.58M | 4.74% | 1,944,159 | 65.34K |
| 361 | GUTS | Fractyl Health, Inc. | 117.40M | -1.08% | 174,042 | 3.00K |
| 362 | BMEA | Biomea Fusion, Inc. | 116.76M | -0.92% | 439,673 | - |
| 363 | CBUS | Cibus, Inc. | 113.66M | -0.67% | 28,997 | 3.64M |
| 364 | CUE | Cue Biopharma, Inc. | 112.70M | -3.11% | 42,744 | 27.47M |
| 365 | CRDF | Cardiff Oncology, Inc. | 112.13M | 2.50% | 66,602 | 593.00K |
| 366 | ENGN | enGene Therapeutics Inc. | 111.20M | -3.49% | 3,797,512 | - |
| 367 | TTRX | Turn Therapeutics Inc. | 109.69M | -2.97% | 12,124 | - |
| 368 | CGTX | Cognition Therapeutics, Inc. | 105.44M | 1.72% | 183,159 | - |
| 369 | SEER | Seer, Inc. | 105.22M | -0.80% | 47,898 | 16.58M |
| 370 | ALDX | Aldeyra Therapeutics, Inc. | 103.75M | -0.58% | 175,471 | - |
| 371 | ONCY | Oncolytics Biotech Inc. | 102.19M | -2.22% | 146,416 | - |
| 372 | VANI | Vivani Medical, Inc. | 101.93M | -0.48% | 35,204 | - |
| 373 | NRXP | NRx Pharmaceuticals, Inc. | 101.42M | 0.33% | 235,362 | 1.23M |
| 374 | NRXS | NeurAxis, Inc. | 100.21M | -1.02% | 35,411 | 3.57M |
| 375 | ANIX | Anixa Biosciences, Inc. | 98.95M | -0.30% | 24,702 | - |
| 376 | COYA | Coya Therapeutics, Inc. | 97.23M | -1.31% | 65,903 | 7.95M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 96.82M | 4.19% | 89,487 | 1.63M |
| 378 | RNTX | Rein Therapeutics Inc. | 92.87M | 1.71% | 101,814 | - |
| 379 | LONA | LeonaBio, Inc. | 92.53M | -0.10% | 4,146 | - |
| 380 | ACET | Adicet Bio, Inc. | 91.85M | 2.70% | 39,524 | - |
| 381 | QTTB | Q32 Bio Inc. | 91.56M | -0.74% | 21,613 | 53.74M |
| 382 | ATYR | aTyr Pharma, Inc. | 91.55M | 1.29% | 160,553 | 190.00K |
| 383 | ATHE | Alterity Therapeutics Limited | 86.71M | 1.29% | 2,583 | 4.43M |
| 384 | PMN | ProMIS Neurosciences, Inc. | 85.46M | -3.05% | 11,791 | - |
| 385 | EXOZ | eXoZymes, Inc. | 84.79M | - | 112 | -700.00 |
| 386 | OKYO | OKYO Pharma Limited | 84.49M | -0.62% | 8,917 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 83.99M | 4.21% | 773 | 16.80M |
| 388 | PYPD | PolyPid Ltd. | 83.97M | -0.79% | 15,902 | - |
| 389 | CSBR | Champions Oncology, Inc. | 81.79M | -1.67% | 5,006 | 57.95M |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 80.20M | 1.97% | 51,227 | - |
| 391 | ANVS | Annovis Bio, Inc. | 80.12M | 2.65% | 230,306 | - |
| 392 | FBIO | Fortress Biotech, Inc. | 79.23M | -0.63% | 13,190 | 63.26M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 78.27M | -1.53% | 26,109 | - |
| 394 | ATRA | Atara Biotherapeutics, Inc. | 77.72M | -8.06% | 1,520,239 | 120.77M |
| 395 | GOSS | Gossamer Bio, Inc. | 77.68M | -3.70% | 823,805 | 48.47M |
| 396 | GANX | Gain Therapeutics, Inc. | 77.63M | -2.67% | 123,598 | - |
| 397 | TCRX | TScan Therapeutics, Inc. | 77.53M | 6.61% | 430,807 | 9.14M |
| 398 | ICCC | ImmuCell Corporation | 76.81M | 0.24% | 316 | 27.64M |
| 399 | PLRX | Pliant Therapeutics, Inc. | 76.46M | -0.40% | 29,021 | - |
| 400 | RLYB | Rallybio Corporation | 76.44M | -1.43% | 24,614 | 858.00K |
| 401 | XBIT | XBiotech Inc. | 76.22M | - | 2,922 | - |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 75.73M | - | 42,071 | - |
| 403 | ACTU | Actuate Therapeutics, Inc. | 75.64M | -4.49% | 33,489 | - |
| 404 | MCRB | Seres Therapeutics, Inc. | 73.40M | -1.30% | 1,896 | 1.15M |
| 405 | OSTX | OS Therapies Incorporated | 71.47M | - | 46,859 | - |
| 406 | MNOV | MediciNova, Inc. | 69.89M | -0.70% | 1,268 | 409.66K |
| 407 | IBO | Impact BioMedical Inc. | 65.82M | -2.65% | 24,403 | 32.00K |
| 408 | PDSB | PDS Biotechnology Corporation | 65.30M | 2.63% | 135,165 | - |
| 409 | KALA | KALA BIO, Inc. | 63.21M | -18.17% | 2,952,908 | - |
| 410 | FLNA | Filana Therapeutics, Inc. | 63.04M | -4.04% | 75,903 | - |
| 411 | IMMP | Immutep Limited | 63.02M | 1.18% | 211,908 | 5.28M |
| 412 | CING | Cingulate Inc. | 62.72M | -2.10% | 102,634 | - |
| 413 | IMA | ImageneBio, Inc. | 62.19M | -5.92% | 14,129 | 800.00K |
| 414 | HYFT | MindWalk Holdings Corp. | 61.83M | 3.75% | 67,928 | 20.70M |
| 415 | BYSI | BeyondSpring Inc. | 61.68M | 5.63% | 1,611 | 1.88M |
| 416 | ENTX | Entera Bio Ltd. | 60.84M | -4.74% | 88,780 | 42.00K |
| 417 | IBIO | iBio, Inc. | 59.09M | -0.30% | 85,627 | 300.00K |
| 418 | LIXT | Lixte Biotechnology Holdings, Inc. | 56.00M | -2.23% | 3,908 | - |
| 419 | INKT | MiNK Therapeutics, Inc. | 55.16M | -0.73% | 925 | - |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 55.11M | 5.77% | 35,161 | - |
| 421 | TIL | Instil Bio, Inc. | 54.81M | 0.64% | 1,174 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 54.08M | -0.54% | 29,681 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 53.04M | -0.78% | 38,595 | 25.21M |
| 424 | ESLA | Estrella Immunopharma, Inc. | 52.90M | -2.36% | 8,509 | - |
| 425 | RADX | Radiopharm Theranostics Limited | 48.81M | -2.17% | 27,241 | 10.86M |
| 426 | ATOS | Atossa Therapeutics, Inc. | 48.22M | -1.23% | 5,880 | - |
| 427 | XLO | Xilio Therapeutics, Inc. | 46.27M | -0.99% | 11,803 | 43.77M |
| 428 | NTRB | Nutriband Inc. | 44.73M | -2.90% | 502 | 2.04M |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | -1.52% | 18,863 | - |
| 430 | HYPD | Hyperion DeFi, Inc. | 43.29M | 6.44% | 366,368 | 813.46K |
| 431 | PSTV | Plus Therapeutics, Inc. | 41.86M | 2.52% | 24,040 | 5.21M |
| 432 | LITS | Lite Strategy, Inc. | 41.82M | 0.88% | 99,187 | - |
| 433 | ALGS | Aligos Therapeutics, Inc. | 40.04M | 7.30% | 215,193 | 2.19M |
| 434 | TVRD | Tvardi Therapeutics, Inc. | 39.78M | 0.71% | 17,789 | - |
| 435 | MREO | Mereo BioPharma Group plc | 39.74M | 3.75% | 332,883 | 500.00K |
| 436 | RNXT | RenovoRx, Inc. | 39.65M | - | 100,658 | 1.12M |
| 437 | INMB | INmune Bio Inc. | 39.61M | 4.20% | 62,865 | 50.00K |
| 438 | DARE | Daré Bioscience, Inc. | 38.87M | -8.25% | 219,098 | 1.03M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 38.35M | 0.82% | 6,270 | 90.00K |
| 440 | NXTC | NextCure, Inc. | 35.90M | -2.26% | 2,895 | - |
| 441 | VERU | Veru Inc. | 35.79M | -2.19% | 7,778 | 16.89M |
| 442 | CRVO | CervoMed Inc. | 35.65M | 1.32% | 5,457 | 4.01M |
| 443 | EVAX | Evaxion A/S | 35.62M | 4.93% | 8,647 | 7.53M |
| 444 | PLUR | Pluri Inc. | 35.18M | 4.79% | 1,196 | 1.34M |
| 445 | HOWL | Werewolf Therapeutics, Inc. | 34.98M | 16.10% | 1,113,469 | 1.14M |
| 446 | GRCE | Grace Therapeutics, Inc. | 34.97M | 0.44% | 96,362 | - |
| 447 | APLM | Apollomics, Inc. | 34.17M | -2.14% | 290 | 8.84M |
| 448 | BOLD | Boundless Bio, Inc. | 33.63M | -1.96% | 57,448 | - |
| 449 | PTN | Palatin Technologies, Inc. | 33.28M | 2.91% | 657 | 8.96M |
| 450 | NNVC | NanoViricides, Inc. | 31.85M | 3.87% | 118,368 | - |
| 451 | SNSE | Sensei Biotherapeutics, Inc. | 31.69M | -0.51% | 3,466 | - |
| 452 | NRSN | NeuroSense Therapeutics Ltd. | 31.39M | 1.25% | 24,424 | - |
| 453 | TVGN | Tevogen Bio Holdings Inc. | 31.15M | - | 759 | - |
| 454 | IGC | IGC Pharma, Inc. | 31.11M | -1.32% | 34,396 | 1.11M |
| 455 | SKYE | Skye Bioscience, Inc. | 30.57M | -3.11% | 25,007 | - |
| 456 | SNTI | Senti Biosciences Holdings, Inc. | 30.26M | -1.37% | 34,383 | 22.00K |
| 457 | BCTX | BriaCell Therapeutics Corp. | 29.77M | 0.24% | 15,861 | - |
| 458 | QNTM | Quantum BioPharma Ltd. | 29.75M | -1.60% | 17,759 | - |
| 459 | LSTA | Lisata Therapeutics, Inc. | 28.82M | -1.21% | 8,436 | 170.00K |
| 460 | TPST | Tempest Therapeutics, Inc. | 28.76M | 1.78% | 10,846 | - |
| 461 | KYNB | Kyntra Bio, Inc. | 28.74M | -0.14% | 300 | 6.44M |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 28.52M | -0.94% | 9,655 | 14.99M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 28.19M | 3.00% | 5,095 | 14.97M |
| 464 | PLRZ | Polyrizon Ltd. | 27.42M | 3.61% | 46,808 | - |
| 465 | ABVC | ABVC BioPharma, Inc. | 26.93M | -0.91% | 17,198 | 797.92K |
| 466 | JSPR | Jasper Therapeutics, Inc. | 26.23M | 3.13% | 54,041 | - |
| 467 | SER | Serina Therapeutics, Inc. | 26.22M | -2.76% | 18,060 | 130.00K |
| 468 | LGVN | Longeveron Inc. | 25.77M | 3.31% | 15,154 | 1.20M |
| 469 | CELU | Celularity Inc. | 25.67M | -1.93% | 52,162 | 26.55M |
| 470 | DYAI | Dyadic International, Inc. | 25.51M | -6.04% | 54,584 | 3.09M |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 24.96M | 7.36% | 426,666 | 789.00K |
| 472 | MRKR | Marker Therapeutics, Inc. | 24.43M | 1.74% | 19,905 | 3.55M |
| 473 | OTLK | Outlook Therapeutics, Inc. | 23.74M | 5.19% | 1,182,128 | 205.70K |
| 474 | LTRN | Lantern Pharma Inc. | 23.37M | 2.21% | 14,128 | - |
| 475 | ALLR | Allarity Therapeutics, Inc. | 23.04M | -0.67% | 77,339 | 320.00K |
| 476 | CRIS | Curis, Inc. | 22.75M | -1.39% | 44,887 | 9.44M |
| 477 | TRAW | Traws Pharma, Inc. | 22.65M | 31.18% | 61,382,492 | 2.79M |
| 478 | AEON | AEON Biopharma, Inc. | 22.52M | -2.20% | 4,123 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 22.05M | -1.77% | 5,852 | 570.00K |
| 480 | XCUR | Exicure, Inc. | 20.72M | -2.99% | 2,044 | 500.00K |
| 481 | QNCX | Quince Therapeutics, Inc. | 20.54M | -3.08% | 76,941 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 20.51M | -2.09% | 37,770 | - |
| 483 | OSRH | OSR Holdings, Inc. | 20.20M | -11.76% | 1,107,410 | 2.91M |
| 484 | LPCN | Lipocine Inc. | 19.82M | 3.35% | 110,918 | 1.98M |
| 485 | GRDX | GridAI Technologies Corp. | 19.41M | 9.82% | 61,461 | - |
| 486 | COCP | Cocrystal Pharma, Inc. | 19.30M | 0.72% | 22,612 | - |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 18.59M | 0.33% | 9,673 | - |
| 488 | ICU | SeaStar Medical Holding Corporation | 18.59M | -4.32% | 25,920 | 1.23M |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 17.29M | -2.46% | 126,120 | 3.94M |
| 490 | TOVX | Theriva Biologics, Inc. | 15.98M | -3.28% | 509,574 | 300.00K |
| 491 | INAB | IN8bio, Inc. | 15.76M | - | 9,245 | - |
| 492 | LEXX | Lexaria Bioscience Corp. | 15.68M | -1.30% | 12,507 | 368.00K |
| 493 | GNTA | Genenta Science S.p.A. | 15.39M | 1.92% | 3,145 | - |
| 494 | NCEL | NewcelX Ltd. | 15.34M | 3.86% | 897 | - |
| 495 | BLRX | BioLineRx Ltd. | 15.25M | 1.77% | 1,330 | 1.18M |
| 496 | HIND | Vyome Holdings, Inc. | 15.02M | 1.90% | 16,135 | 319.71K |
| 497 | CLRB | Cellectar Biosciences, Inc. | 13.36M | -4.55% | 126,770 | - |
| 498 | CYCN | Cyclerion Therapeutics, Inc. | 13.19M | -0.95% | 11,669 | 2.07M |
| 499 | PHIO | Phio Pharmaceuticals Corp. | 13.13M | -0.88% | 58,930 | - |
| 500 | PBM | Psyence Biomedical Ltd. | 13.12M | -4.98% | 39,243 | - |